Skip Navigation

Treatment of Adult Acute Lymphoblastic Leukemia in Remission

For information about the treatments listed below, see the Treatment Option Overview section.

Standard treatment of adult acute lymphoblastic leukemia (ALL) during the post-remission phase includes the following:

  • Chemotherapy.
  • Tyrosine kinase inhibitor therapy with imatinib, nilotinib, or dasatinib.
  • Chemotherapy with stem cell transplant.
  • Central nervous system (CNS prophylaxis)  therapy including chemotherapy (intrathecal and/or systemic) with or without radiation therapy to the brain.

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

This information is not intended to replace the advice of a doctor. Navigating Care disclaims any liability for the decisions you make based on this information. This information was sourced and adapted from Adapted from the National Cancer Institute's Physician Data Query (PDQ®) Cancer Information Summaries on www.cancer.gov.

See Expert Resources

The Navigating Care Library includes articles about cancer, chemotherapy regimens and drugs from the the National Cancer Institute and other experts.